Full-Time

Director, Regulatory Affairs

Pharmaceuticals

Posted on 9/11/2026

ClinChoice

ClinChoice

1,001-5,000 employees

Global CRO providing full-service clinical development

No salary listed

Horsham, PA, USA

Hybrid

Hybrid work arrangement; specific required office days are not stated.

Bachelor's, Master's, PharmD, PhD

Category
Biology & Biotech (1)

Get referred to ClinChoice

See people who can refer or advise you

Requirements
  • A bachelor's degree in a scientific field.
  • Eight or more years of experience in Regulatory Affairs for biopharmaceutical products, including small and large molecules, drug-device combinations, and vaccines.
  • Experience developing regulatory strategies for Investigational New Drugs, Clinical Trial Applications, New Drug Applications, Marketing Authorization Applications, and/or Biologics License Applications, with a track record of successful approvals.
  • Direct experience working with the Food and Drug Administration and other health authorities.
  • Strong knowledge of Regulatory Affairs throughout the product lifecycle, including Development, Chemistry, Manufacturing and Controls, Labeling, Promotion, Commercialization, and Operations.
  • Ability to assimilate and interpret trends in the life sciences regulatory environment that affect business decisions.
  • Ability to initiate and support development of digital technology solutions for regulatory affairs and operations processes.
  • Ability to build cross-functional relationships and work collaboratively with other groups.
  • Ability to execute project details in a small, fast-paced environment.
Responsibilities
  • Provide strategic and tactical leadership of the regulatory affairs function in North America in collaboration with cross-functional teams.
  • Lead client interactions and serve as a subject matter expert on regulatory projects for biopharmaceutical clients.
  • Ensure compliance with applicable government regulations, industry guidelines, and best practices.
  • Devise and implement global regulatory strategies and provide leadership oversight for client projects in collaboration with global regulatory colleagues.
  • Manage, oversee, and/or prepare regulatory documents and submissions according to client requirements.
  • Serve as a subject matter expert on health-authority regulations for biopharmaceutical products.
  • Collaborate with internal staff to author and compile documents for submission to regulatory agencies, including Investigational New Drug applications, Clinical Trial Applications, Biologics License Applications, Marketing Authorization Applications, and New Drug Applications.
  • Mentor internal teams across regulatory projects.
  • Monitor the regulatory environment and communicate changes and impact assessments to team members.
  • Monitor the regulatory landscape and communicate to senior leadership about impacts of guidelines and policies that may create business opportunities.
  • Hire, develop, and mentor regulatory personnel and future regulatory staff.
  • Prepare client presentations and support department growth activities as needed.
Desired Qualifications
  • An advanced degree such as a Doctor of Pharmacy, Doctor of Philosophy, or Master of Science.
  • Experience with Phase I through Phase III products.
  • Experience with the Center for Biologics Evaluation and Research and global biologics.

ClinChoice provides outsourced clinical development services as a global CRO for pharmaceutical, biotechnology, medical device, and consumer health clients. It supports trials across the full lifecycle with services including clinical operations, biostatistics, data management, regulatory affairs, medical affairs, pharmacovigilance, and project management, and it offers project-based or Functional Service Provider (FSP) engagement models. The company differentiates itself through its scale and international reach (4,000+ professionals in 30+ countries) and a track record of 1,500+ full-service studies, aided by growth from mergers and acquisitions. Its goal is to help clients accelerate drug and device approvals by efficiently managing multinational trials and navigating complex regulatory environments throughout development and post-marketing.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Whitemarsh Township, Pennsylvania

Founded

1995

Get referred to ClinChoice

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Monash University partnered with ClinChoice on March 23, 2026 for early-phase trials.
  • Revelio Labs reported 2,339 employees in March 2026 and 133 active 2026 postings.
  • Legend Capital's 2022 $150 million round still funds expansion and acquisition capacity.

What critics are saying

  • Revelio Labs shows active postings fell 27.8% in 2026, signaling weaker demand.
  • ClinChoice's workforce slipped from 2,348 in 2023 to 2,339 in 2026.
  • A failed integration of CROMSOURCE, CSI, and Medidata systems would break delivery quality.

What makes ClinChoice unique

  • ClinChoice spans 30+ countries, enabling multinational trials across Asia, Europe, and North America.
  • Its 2023 CROMSOURCE and 2024 CSI acquisitions deepened full-service and Southeast Asia reach.
  • The 2024 Medidata extension adds Clinical Data Studio to its data-management stack.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

7%

1 year growth

7%

2 year growth

7%
PR Newswire
Jan 12th, 2024
ClinChoice Acquires CSI, Expanding its Global Footprint into Southeast Asia

/PRNewswire/ -- ClinChoice, a leading global Contract Research Organization (CRO), today announced expanding its global footprint with the acquisition of CSI...

TalentSource Life Sciences
Mar 20th, 2023
Outsourcing in Clinical Trials Southeast 2023 – TalentSource Life Sciences

On March 1 st, 2023 ClinChoice acquired CROMSOURCE, strengthening its global network and deepening its full-service capabilities.

AVCJ
Jul 6th, 2022
Legend Capital invests into ClinChoice Inc. in $150M

US and China-based clinical contract research organization (CRO) company ClinChoice has raised a USD 150m Series E round led by Legend Capital.

Endpoints News
Jul 5th, 2022
Fountain Medical Development Ltd receives financing of $150M in Series E funding round

ClinChoice, formerly Fountain Medical Development, has completed a $150 million Series E funding round, using the cash to continue its planned expansion.

The HealthCo
Apr 13th, 2022
Cloudbyz, Inc. partnered with ClinChoice Inc. on Apr 13th 22'.

Cloudbyz, a fast-growing integrated clinical research and development solution provider with integrated capabilities, today announced a partnership with ClinChoice, a global full-service clinical CRO dedicated to offering high-quality one-stop service to biopharmaceutical, Vaccine, Medical Device, Cosmetics, Nutraceuticals, and Consumer Products clients.